The Drug Manufacturers - General industry includes 67 US-listed stocks with an average AI MoonshotScore of 54/100. Top-scored names: LLY, BMY, JNJ.
The Drug Manufacturers - General industry includes 67 US-listed stocks with an average AI MoonshotScore of 54/100. Top-scored names: LLY, BMY, JNJ.
Complete list of 67 Drug Manufacturers - General industry stocks with AI-powered MoonshotScore analysis, real-time price data, and institutional-grade market insights.
The Drug Manufacturers - General industry comprises 67 publicly traded companies with a combined market capitalization of $7.4T. This includes 13 mega-cap companies (over $200B), reflecting the industry's significant weight in global markets.
Today's market sentiment for Drug Manufacturers - General stocks is Bearish, with 16 stocks advancing and 27 declining. The average price movement across the industry is +61412.48%.
The average AI MoonshotScore across Drug Manufacturers - General stocks is 54/100, indicating above-average growth potential based on our proprietary analysis combining fundamentals, technicals, and sentiment.
How Drug Manufacturers - General companies are distributed across market capitalization tiers.
There are currently 67 publicly traded companies classified under the Drug Manufacturers - General industry. The tracked companies carry a combined market capitalization of $7.4T, with 16 advancing and 27 declining in today's trading.
Based on our AI MoonshotScore analysis, the top-rated Drug Manufacturers - General stocks are LLY, BMY, JNJ. Always conduct your own research before investing.
The largest Drug Manufacturers - General companies by market capitalization are LLY ($1.17T), BMYMP ($814.59B), JNJ ($644.33B). Across the tracked list, the median market capitalization is $13.4B — a gauge of how top-heavy the industry is beyond its largest names.
The current average MoonshotScore for the Drug Manufacturers - General industry is 54/100. The strongest current score in the industry is 97/100 — each stock is rated across fundamentals, technical indicators, and market sentiment.
Drug Manufacturers - General stocks are tracked against broader market benchmarks. You can compare sector and industry performance on our Market Sectors dashboard.
Stock Expert AI evaluates every publicly traded U.S. stock using the MoonshotScore, a proprietary 0–100 composite rating. U.S.-listed common stocks are scored against their sector peers across five pillars: business quality, financial safety, valuation, growth durability, and momentum. ETFs, OTC names, and foreign listings use a legacy nine-signal quantitative model spanning growth, margins, cash position, insider activity, liquidity, momentum, and news sentiment.
Price data is sourced from Financial Modeling Prep (FMP) with Yahoo Finance as a fallback. Fundamental data comes from SEC filings, FMP, and Alpha Vantage. Sentiment signals are derived from aggregated analyst ratings and news flow. All metrics refresh during market hours; after-hours data reflects the most recent closing values.
Sector and industry classifications follow the Global Industry Classification Standard (GICS), the same taxonomy used by S&P and MSCI. Companies are assigned to one of 11 sectors and further classified into 50+ industries based on their primary revenue source.
Data is provided for informational purposes only and should not be considered investment advice. Stock prices, market capitalizations, and MoonshotScores are updated throughout the trading day. Past performance does not guarantee future results. Always consult with a qualified financial advisor before making investment decisions.
| Stock | Price | Change | Volume | Market Cap | MoonshotScore | Sector |
|---|---|---|---|---|---|---|
|
LLY
Eli Lilly and Company
|
$1245.69 | -2.71% | 1.75M | $1.17T | 97 | Healthcare |
|
BMY
Bristol-Myers Squibb Company
|
$65.47 | -3.17% | 9.49M | $133.74B | 89 | Healthcare |
|
JNJ
Johnson & Johnson
|
$267.37 | -2.21% | 6.47M | $644.33B | 89 | Healthcare |
|
AMGN
Amgen Inc.
|
$433.73 | -1.95% | 2.91M | $234.09B | 86 | Healthcare |
|
ABBV
AbbVie Inc.
|
$265.06 | -0.34% | 2.16M | $468.30B | 82 | Healthcare |
|
MRK
Merck & Co., Inc.
|
$149.25 | -1.94% | 14M | 369B | 75 | Healthcare |
|
CRXTQ
Clarus Therapeutics Holdings, Inc.
|
$0.00 | +0.00% | 38.3K | $72,829 | 68 | Healthcare |
|
PFE
Pfizer Inc.
|
$27.82 | -1.50% | 23.72M | $158.53B | 67 | Healthcare |
|
ORINY
Orion Oyj
|
$43.02 | +0.00% | 4 | $24.22B | 64 | Healthcare |
|
BIIB
Biogen Inc.
|
$217.35 | -1.90% | 244.5K | $32.11B | 64 | Healthcare |
|
ORINF
Orion Oyj
|
$82.75 | +0.00% | 100 | $11.66B | 63 | Healthcare |
|
GILD
Gilead Sciences, Inc.
|
$143.44 | -2.82% | 6.46M | $178.09B | 62 | Healthcare |
|
AZN
AstraZeneca PLC
|
$164.49 | -0.28% | 5.09M | $255.10B | 61 | Healthcare |
|
GSK
GSK plc
|
$51.96 | -1.74% | 3.60M | $104.10B | 61 | Healthcare |
|
RHHBY
Roche Holding AG
|
$57.25 | -1.63% | 877.8K | $364.95B | 61 | Healthcare |
|
AZNCF
AstraZeneca PLC
|
$189.90 | -1.35% | 1.43M | $294.40B | 60 | Healthcare |
|
OPHLF
Ono Pharmaceutical Co., Ltd.
|
$16.00 | +9.51% | 151 | $7.52B | 59 | Healthcare |
|
ALPMF
Astellas Pharma Inc.
|
$16.45 | +8.22% | 212 | $29.47B | 58 | Healthcare |
|
GLAXF
GSK plc
|
$25.35 | +0.00% | 150 | $101.57B | 58 | Healthcare |
|
OTSKF
Otsuka Holdings Co., Ltd.
|
$77.53 | +0.00% | 4 | $40.73B | 58 | Healthcare |
|
OTSKY
Otsuka Holdings Co., Ltd.
|
$39.39 | +2.36% | 3.4K | $41.39B | 58 | Healthcare |
|
SNY
Sanofi
|
$45.44 | -0.85% | 331.9K | $109.11B | 58 | Healthcare |
|
CELG-RI
Bristol-Myers Squibb Company Ce
|
$0.10 | +2.31% | 15.0K | $208.36M | 57 | Healthcare |
|
KYKOF
Kyowa Kirin Co., Ltd.
|
$14.43 | +0.00% | 17 | $7.55B | 57 | Healthcare |
|
NVS
Novartis AG
|
$156.24 | -2.54% | 1.53M | $296.97B | 57 | Healthcare |
|
CRXT
Clarus Therapeutics Holdings, Inc.
|
$0.05 | -31.16% | 2.74M | 0 | 56 | Healthcare |
|
ALPMY
Astellas Pharma Inc.
|
$14.96 | -1.12% | 15.7K | $26.82B | 55 | Healthcare |
|
CHGCF
Chugai Pharmaceutical Co., Ltd.
|
$43.09 | +0.61% | 408 | $70.91B | 55 | Healthcare |
|
CHGCY
Chugai Pharmaceutical Co., Ltd.
|
$22.09 | -0.45% | 5.4K | $72.71B | 55 | Healthcare |
|
DSKYF
Daiichi Sankyo Company, Limited
|
$18.00 | +2.78% | 100 | $32.75B | 55 | Healthcare |
|
DSNKY
Daiichi Sankyo Company, Limited
|
$18.04 | +2.56% | 26.7K | $32.84B | 55 | Healthcare |
|
NVSEF
Novartis AG
|
$157.61 | -1.49% | 377 | $299.57B | 55 | Healthcare |
|
HZNP
Horizon Therapeutics Public Limited Company
|
$116.30 | +0.00% | 23.92M | $26.60B | 54 | Healthcare |
|
OPHLY
Ono Pharmaceutical Co., Ltd.
|
$5.15 | -0.58% | 1 | $7.26B | 54 | Healthcare |
|
RCDTF
Recordati Industria Chimica e Farmaceutica S.p.A.
|
$58.00 | +0.00% | 100 | $11.88B | 54 | Healthcare |
|
RHHBF
Roche Holding AG
|
$465.00 | +5.68% | 65 | $370.50B | 54 | Healthcare |
|
RHHVF
Roche Holding AG
|
$458.51 | -1.27% | 1.1K | $315.88B | 54 | Healthcare |
|
VRBCF
Virbac S.A.
|
$383.25 | +0.00% | 1 | $3.21B | 54 | Healthcare |
|
BDSIW
BioDelivery Sciences Intl, Inc. Wrrt
|
$0.04 | -25.00% | 552.1K | 0 | 52 | Healthcare |
|
GIFLF
Grifols, S.A.
|
$11.76 | +0.00% | 5.8K | $8.00B | 52 | Healthcare |
|
GIFOF
Grifols, S.A.
|
$8.85 | +0.00% | 149 | $8.70B | 52 | Healthcare |
|
BAYRY
Bayer AG
|
$14.12 | -1.74% | 26.3K | $55.49B | 51 | Healthcare |
|
BMYMP
Bristol-Myers Squibb Company PFD CONV 2
|
$400.00 | -57.46% | 13 | $814.59B | 50 | Healthcare |
|
CHJTF
CSPC Pharmaceutical Group Limited
|
$1.11 | +0.00% | 2.0K | $12.66B | 50 | Healthcare |
|
HAWPY
Haw Par Corporation Limited
|
$53.50 | +0.00% | 7 | $2.96B | 50 | Healthcare |
|
HAWPF
Haw Par Corporation Limited
|
$12.58 | +0.00% | 200 | $2.78B | 49 | Healthcare |
|
LYPHF
Luye Pharma Group Ltd.
|
$0.27 | +0.00% | 2.5K | $1.08B | 49 | Healthcare |
|
CSPCY
CSPC Pharmaceutical Group Limited
|
$4.39 | +0.00% | 400 | $12.65B | 48 | Healthcare |
|
DPHAY
Dechra Pharmaceuticals PLC
|
$98.00 | +1.98% | 100 | 6B | 48 | Healthcare |
|
GIKLY
Grifols, S.A.
|
$5.10 | +0.00% | 1 | $13.40B | 48 | Healthcare |
|
JCRRF
JCR Pharmaceuticals Co., Ltd.
|
$3.32 | +0.00% | 600 | $405.10M | 48 | Healthcare |
|
PSYGF
Psyence Group Inc.
|
$0.14 | +9.76% | 100 | $2.25M | 48 | Healthcare |
|
SNYNF
Sanofi
|
$90.53 | +0.00% | 115 | $108.69B | 48 | Healthcare |
|
TGRNF
Tong Ren Tang Technologies Co. Ltd.
|
$0.49 | +0.00% | 1.0K | $633.86M | 48 | Healthcare |
|
PTKFF
PT Kalbe Farma Tbk.
|
$0.04 | +0.00% | 10.0K | $1.82B | 47 | Healthcare |
|
PTKFY
PT Kalbe Farma Tbk.
|
$9.49 | +12.53% | 73 | $10.75M | 47 | Healthcare |
|
SNPHF
Santen Pharmaceutical Co., Ltd.
|
$13.05 | +0.00% | 2.0K | $4.20B | 47 | Healthcare |
|
MIRA
MIRA Pharmaceuticals, Inc.
|
$0.71 | -7.79% | 35.5K | $29.84M | 45 | Healthcare |
|
GRFS
Grifols, S.A. is a global healthcare company focused on plasma-derived medicines and other innovative solutions. The company
|
$7.99 | -3.15% | 293.6K | $6.76B | 45 | Healthcare |
|
SNPHY
Santen Pharmaceutical Co., Ltd.
|
$12.40 | +3.94% | 105 | $3.99B | 44 | Healthcare |
|
TCRG
The Cannaisseur Group, Inc.
|
$0.06 | +4114731.80% | 350 | $1.11M | 44 | Healthcare |
|
MAYNF
Mayne Pharma Group Limited
|
$2.29 | +0.00% | 3.0K | $186.05M | 43 | Healthcare |
|
SRXH
SRx Health Solutions Inc.
|
$1.81 | -3.21% | 390.7K | $17.81M | 39 | Healthcare |
|
OGN
Organon & Co.
|
$13.74 | +0.07% | 4.05M | $3.61B | 35 | Healthcare |
|
SCLX
Scilex Holding Company
|
$5.80 | +2.65% | 29.7K | $49.25M | 17 | Healthcare |
|
CTOR
Citius Oncology, Inc.
|
$0.76 | +0.88% | 52.1K | $70.58M | 16 | Healthcare |
|
SCLXW
Scilex Holding Company
|
$0.16 | +0.00% | 0 | $44.74M | 0 | Healthcare |